Comprehensive Psychiatry
Volume 48, Issue 6 , Pages 516-521, November 2007

Eating disorders and illness burden in patients with bipolar spectrum disorders

Portions of this article were presented at the 2007 International Conference on Eating Disorders, Baltimore, MD, May 2-5, and the Seventh International Conference on Bipolar Disorder, Pittsburgh, PA, June 7-9, 2007.

Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA

published online 20 August 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr Marcus has served as a consultant to GlaxoSmithKline and Sanofi Aventis. Dr Fagiolini is on the advisory board for Pfizer Inc and Bristol-Meyers Squibb and is in the speaker bureau of Bristol-Meyers Squibb, Eli Lilly Italy, Pfizer Inc, and Shire.

PII: S0010-440X(07)00076-4

doi:10.1016/j.comppsych.2007.05.012

Comprehensive Psychiatry
Volume 48, Issue 6 , Pages 516-521, November 2007